Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.93
-0.63 (-3.06%)
At close: Dec 5, 2025, 4:00 PM EST
20.32
+0.39 (1.96%)
After-hours: Dec 5, 2025, 4:15 PM EST
Forte Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 11.7 | 15.41 | 10.62 | 8.3 | 7.63 | 4.22 | |
| Research & Development | 41.74 | 21.19 | 21.86 | 5.59 | 13.85 | 10 | |
| Operating Expenses | 53.44 | 36.6 | 32.49 | 13.9 | 21.49 | 14.23 | |
| Operating Income | -53.44 | -36.6 | -32.49 | -13.9 | -21.49 | -14.23 | |
| Interest & Investment Income | 1.31 | 1.31 | 1.12 | 0.16 | - | - | |
| Other Non Operating Income (Expenses) | 0.14 | -0.19 | -0.11 | -0.15 | -0.22 | -0.21 | |
| EBT Excluding Unusual Items | -51.99 | -35.48 | -31.48 | -13.88 | -21.71 | -14.43 | |
| Pretax Income | -51.74 | -35.48 | -31.48 | -13.88 | -21.71 | -46.49 | |
| Net Income | -51.74 | -35.48 | -31.48 | -13.88 | -21.71 | -46.49 | |
| Net Income to Common | -51.74 | -35.48 | -31.48 | -13.88 | -21.71 | -46.49 | |
| Shares Outstanding (Basic) | 12 | 3 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 12 | 3 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 538.39% | 130.90% | 81.61% | 24.45% | 89.81% | 249.05% | |
| EPS (Basic) | -4.39 | -12.17 | -24.92 | -19.96 | -38.85 | -157.93 | |
| EPS (Diluted) | -4.39 | -12.17 | -24.92 | -19.96 | -38.85 | -157.93 | |
| Free Cash Flow | -44.57 | -30.78 | -28.79 | -8.19 | -16.68 | -18.42 | |
| Free Cash Flow Per Share | -3.78 | -10.56 | -22.80 | -11.77 | -29.85 | -62.59 | |
| EBITDA | -53.38 | -36.56 | -32.48 | -13.86 | -21.45 | -14.17 | |
| D&A For EBITDA | 0.06 | 0.04 | 0.01 | 0.04 | 0.04 | 0.05 | |
| EBIT | -53.44 | -36.6 | -32.49 | -13.9 | -21.49 | -14.23 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.